Q02750

Background

Protein Name
Dual specificity mitogen-activated protein kinase kinase 1
Gene Name
MAP2K1
Organism
Homo sapiens

Annotations

Function
Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Mapping Statistics

Site Maximum Consensus Site Population Minimum Consensus Site Population Median Consensus Site Population
MPP 24 2 15.0
AAS 19 3 12.5
MT3 22 1 16.0
ATP 18 2 15.0
DFG 13 2 7.5
CMP 23 2 12.5
DRS 17 3 8.0
PDIG 9 2 3.5
PIF 19 19 19.0

Mapping Results

PDB ID Maximum Consensus Site Population
MPP site AAS site MT3 site LBP site ATP site DEF site DFG site CMP site PMP site EDI site DRS site PDIG site PIF site
Total Druggable Structures per Site 22 2 33 0 18 0 0 6 0 0 2 0 1
4ANB 0 14 16 0 4 0 0 0 0 0 7 0 0
3W8Q 16 16 16 0 16 0 0 15 0 0 14 0 0
3SLS 22 0 18 0 4 0 0 0 0 0 7 0 0
AFQ02750 0 0 0 0 0 0 13 16 0 0 0 0 0
3ZLW 7 0 17 0 16 0 0 16 0 0 15 6 0
4AN3 2 0 16 0 0 0 0 0 0 0 8 0 0
3EQB 17 0 19 0 17 0 0 6 0 0 3 0 0
3EQG 22 0 16 0 0 0 0 0 0 0 4 0 0
3E8N 23 0 18 0 9 0 0 3 0 0 4 0 0
4MNE 16 3 20 0 17 0 0 0 0 0 17 0 19
3EQF 9 0 20 0 6 0 0 20 0 0 7 0 0
4U81 16 0 19 0 16 0 0 14 0 0 12 0 0
3DY7 8 0 17 0 16 0 0 0 0 0 5 0 0
2P55 23 0 17 0 18 0 2 13 0 0 6 0 0
3VVH 0 0 18 0 17 0 0 8 0 0 14 3 0
3EQH 14 0 18 0 5 0 0 0 0 0 4 3 0
3ZLX 9 0 13 0 15 0 0 15 0 0 15 6 0
5BX0 11 0 8 0 9 0 0 2 0 0 13 4 0
3EQC 9 0 16 0 2 0 0 23 0 0 6 4 0
1S9J 24 0 17 0 16 0 0 15 0 0 9 0 0
3OS3 17 0 17 0 17 0 0 0 0 0 10 0 0
3EQD 15 0 18 0 2 0 0 4 0 0 10 2 0
3ZLY 7 0 14 0 16 0 0 17 0 0 15 4 0
3V04 22 0 16 0 15 0 0 12 0 0 5 0 0
3MBL 23 0 16 0 8 0 0 13 0 0 10 0 0
5EYM 16 0 0 0 11 0 0 16 0 0 16 5 0
3V01 20 0 17 0 15 0 0 12 0 0 7 0 0
4AN2 0 19 16 0 4 0 0 0 0 0 4 0 0
3PP1 22 0 16 0 9 0 0 5 0 0 6 0 0
3EQI 22 0 16 0 3 0 0 3 0 0 6 0 0
4AN9 0 12 21 0 2 0 0 0 0 0 8 2 0
3DV3 16 0 16 0 12 0 0 0 0 0 9 0 0
3ZLS 19 0 8 0 15 0 0 11 0 0 13 0 0
3ORN 0 0 16 0 17 0 0 0 0 0 6 2 0
4ARK 17 0 22 0 16 0 0 10 0 0 10 2 0
4LMN 20 0 18 0 17 0 0 10 0 0 9 0 0
3ZM4 8 0 13 0 16 0 0 13 0 0 15 9 0
3WIG 3 0 19 0 18 0 0 0 0 0 5 0 0
4U80 21 0 20 0 16 0 0 15 0 0 11 2 0
4U7Z 17 0 19 0 17 0 0 14 0 0 8 0 0